SPC5001 / Roche  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
SPC5001 / Roche
NCT01350960: Multiple Ascending Dose Study of SPC5001 in Treatment of Healthy Subjects and Subjects With FH

Terminated
1
24
Europe
SPC5001, Saline 0.9%
Santaris Pharma A/S
Hypercholesterolemia
10/11
11/11

Download Options